The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy
Open accessAbstract
Dysregulation of extracellular matrix (ECM) deposition and cellular metabolism promotes tumor aggressiveness by sustaining the activity of key growth, invasion, and survival pathways. Yet mechanisms by which biophysical properties of ECM relate to metabolic processes and tumor progression remain undefined. In both cancer cells and carcinoma-associated fibroblasts (CAFs), we found that ECM stiffening mechanoactivates glycolysis and glutamine metabolism and thus coordinates non-essential amino acid flux within the tumor niche. Specifically, we demonstrate a metabolic crosstalk between CAF and cancer cells in which CAF-derived aspartate sustains cancer cell proliferation, while cancer cell-derived glutamate balances the redox state of CAFs to promote ECM remodeling. Collectively, our findings link mechanical stimuli to dysregulated tumor metabolism and thereby highlight a new metabolic network within tumors in which diverse fuel sources are used to promote growth and aggressiveness. Furthermore, this study identifies potential metabolic drug targets for therapeutic development in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R., Côme, C., Savagner, P., Gitelman, I., Richardson, A. L., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,917
The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1
Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., & Sabatini, D. M. (2008) · Science · doi:10.1126/science.1157535 · Cited by 2,773
Understanding the Intersections between Metabolism and Cancer Biology
Heiden, M. G. V., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,369
Hippo pathway in organ size control, tissue homeostasis, and cancer
Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 392
Perivascular niches: critical hubs in cancer evolution
Nowosad, A., Marine, J., & Karras, P. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.06.010 · Cited by 60
Extracellular matrix in cancer progression and therapy
He, X., Lee, B., & Jiang, Y. (2022) · Medical Review · doi:10.1515/mr-2021-0028 · Cited by 67
The extracellular matrix in cancer: from understanding to targeting
Chitty, J. L., & Cox, T. R. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.05.003 · Cited by 56
Therapy-Induced Modulation of the Tumor Microenvironment: New Opportunities for Cancer Therapies
Benavente, S., Sánchez-García, A., Naches, S., LLeonart, M. E., & Lorente, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.582884 · Cited by 57
The role of matrix stiffness in cancer stromal cell fate and targeting therapeutic strategies
Wei, J., Yao, J., Yan, M., Xie, Y., Liu, P., Mao, Y., & Li, X. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.08.005 · Cited by 57
Wang, X., Shi, X. J., Lu, H., Zhang, C., Li, X., Zhang, T., Shen, J., & Wen, J. (2022) · Advanced Science · doi:10.1002/advs.202200546 · Cited by 56
Zhang, Y., Xiong, X., Huai, Y., Dey, A., Hossen, M. N., Roy, R. V., Elechalawar, C. K., Rao, G., Bhattacharya, R., & Mukherjee, P. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00262 · Cited by 53
Luo, J., Sun, T., Liu, Z., Liu, Y., Liu, J., Wang, S., Shi, X., & Zhou, H. (2025) · International Journal of Oral Science · doi:10.1038/s41368-025-00380-w · Cited by 61
Liang, T., Zhang, B., Xing, Z., Dong, Y., Xu, H., Chen, X., Jiang, L., Zhu, J., & Min, Q. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202102180 · Cited by 53
Turning up a new pattern: Identification of cancer-associated fibroblast-related clusters in TNBC
Xie, J., Zheng, S., Zou, Y., Tang, Y., Tian, W., Wong, C., Wu, S., Ou, X., Zhao, W., Cai, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1022147 · Cited by 53
Correlation between the Warburg effect and progression of triple-negative breast cancer
Liu, S., Li, Y., Yuan, M., Song, Q., & Liu, M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1060495 · Cited by 58
Ye, Y., Zhang, R., & Feng, H. (2020) · Cell Biology International · doi:10.1002/cbin.11390 · Cited by 51
Tumor Cells and Cancer-Associated Fibroblasts: An Updated Metabolic Perspective
Gentric, G., & Mechta‐Grigoriou, F. (2021) · Cancers · doi:10.3390/cancers13030399 · Cited by 52
Extracellular Matrix Stiffness in Lung Health and Disease
Guo, T., He, C., Venado, A. E., & Zhou, Y. (2022) · Comprehensive physiology · doi:10.1002/cphy.c210032 · Cited by 104
Importance of the Microenvironment and Mechanosensing in Adipose Tissue Biology
Lecoutre, S., Lambert, M., Drygalski, K., Dugail, I., Maqdasy, S., Hautefeuille, M., & Clément, K. (2022) · Cells · doi:10.3390/cells11152310 · Cited by 56
Tian, G., & Ren, T. (2023) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2023.151288 · Cited by 51
LOX inhibition downregulates MMP-2 and MMP-9 in gastric cancer tissues and cells
Жао, Л., Niu, H., Liu, Y., Wang, L., Zhang, N., Zhang, G., Liu, R., & Han, M. (2019) · Journal of Cancer · doi:10.7150/jca.33223 · Cited by 47
Mechanical forces: The missing link between idiopathic pulmonary fibrosis and lung cancer
Wang, C., & Yang, J. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151234 · Cited by 49
Zheng, J.-H., Zhu, Y.-H., Yang, J., Ji, P., Zhao, R.-K., Duan, Z., Yao, H., Jia, Q.-Y., Yin, Y., Hu, L.-P., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114633 · Cited by 54
Tajaldini, M., Saeedi, M., Amiriani, T., Amiriani, A., Sedighi, S., Zadeh, F. M., Dehghan, M. H., Jahanshahi, M., Zanjan, M. G., Khalili, P., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175087 · Cited by 46
Dietary intake and glutamine-serine metabolism control pathologic vascular stiffness
Rachedi, N., Tang, Y., Tai, Y.-Y., Zhao, J., Chauvet, C., Grynblat, J., Akoumia, K. K. F., Estephan, L. E., Torrino, S., Sbai, C., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.010 · Cited by 49
Self-citationZhu, Y., Chen, J., Chen, C., Tang, R., Xu, J., Shi, S., & Yu, X. (2025) · Biomarker Research · doi:10.1186/s40364-025-00727-9 · Cited by 45
Metabolites and Immune Response in Tumor Microenvironments
Cortellino, S., & Longo, V. D. (2023) · Cancers · doi:10.3390/cancers15153898 · Cited by 43
Extracellular Citrate Fuels Cancer Cell Metabolism and Growth
Haferkamp, S., Drexler, K., Federlin, M., Schlitt, H. J., Berneburg, M., Adamski, J., Gaumann, A. K. A., Geissler, E. K., Ganapathy, V., Parkinson, E. K., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.602476 · Cited by 44
Mapping the Metabolic Networks of Tumor Cells and Cancer-Associated Fibroblasts
Karta, J., Bossicard, Y., Kotzamanis, K., Dolznig, H., & Letellier, E. (2021) · Cells · doi:10.3390/cells10020304 · Cited by 41
A Quick Guide to CAF Subtypes in Pancreatic Cancer
Brichkina, A. I., Polo, P., Sharma, S. D., Visestamkul, N., & Lauth, M. (2023) · Cancers · doi:10.3390/cancers15092614 · Cited by 45
Amino acid metabolism in tumor: New shine in the fog?
Qiu, H., Shao, N., Liu, J., Zhao, J.-J., Chen, C., Li, Q., He, Z., Zhao, X., & Xu, L. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.06.011 · Cited by 38
The role of cancer-associated fibroblasts in breast cancer metastasis
Li, Y., Wang, C., Huang, T. H., Yu, X., & Tian, B. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1194835 · Cited by 39
Sung, J., & Cheong, J. (2022) · Cells · doi:10.3390/cells11050768 · Cited by 40
Meng, Q., Luo, X., Chen, J., Wang, D., Chen, E., Zhang, W., Zhang, G., Zhou, W., Xu, J., & Song, Z. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188443 · Cited by 38
The multifaceted mechanisms of malignant glioblastoma progression and clinical implications
Sun, R., & Kim, A. H. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10051-5 · Cited by 40
Targeting methionine metabolism in cancer: opportunities and challenges
Bin, P., Wang, C., Zhang, H., Yan, Y., & Ren, W. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.03.002 · Cited by 37
Zhang, X., Al-Danakh, A., Zhu, X., Feng, D., Yang, L., Wu, H., Li, Y., Wang, S., Chen, Q., & Yang, D. (2024) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10698 · Cited by 36
Tao, D., Wang, H., Chang, S., Cheng, J., Da, N., Zhang, L., Yang, J., Wang, W., Xu, F., & Li, B. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202405097 · Cited by 36
Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology
Fairweather, S. J., Shah, N., & Bröer, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_584 · Cited by 37
Urra, F. A., Fuentes-Retamal, S., Palominos, C., Rodríguez-Lucart, Y. A., López-Torres, C., & Araya‐Maturana, R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.751301 · Cited by 38
Metabolic Reprogramming of Thyroid Cancer Cells and Crosstalk in Their Microenvironment
Bao, L., Xu, T., Lu, X., Huang, P. C., Pan, Z., & Ge, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.773028 · Cited by 37
Development of a CAFs-related gene signature to predict survival and drug response in bladder cancer
Zhang, Z., Liang, Z.-J., Li, D., Wang, L.-P., Chen, Y., Liang, Y., Jiao, W., & Niu, H. (2022) · Human Cell · doi:10.1007/s13577-022-00673-w · Cited by 22
Oncogenic KRAS triggers metabolic reprogramming in pancreatic ductal adenocarcinoma
Shen, X., Niu, N., & Xue, J. (2022) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2022-0022 · Cited by 39
Chen, A., Sun, X. Y., Xiao, S., Guo, L., Shang, M., Shi, D., Meng, D., Zhao, Y., Wang, X., & Li, J. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01979-z · Cited by 35
Nocquet, L., Juin, P. P., & Souazé, F. (2020) · Cancers · doi:10.3390/cancers12103017 · Cited by 34
Sun, Y., Chen, S., Lu, Y., Xu, Z., Fu, W., & Yan, W. (2024) · Communications Biology · doi:10.1038/s42003-024-05765-x · Cited by 33
Exploring the Metabolic Vulnerabilities of Epithelial–Mesenchymal Transition in Breast Cancer
Sun, X., Wang, M., Wang, M., Yao, L., Li, X., Dong, H., Li, M., Li, X., Liu, X., & Xu, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00655 · Cited by 38
Mechanobiology of solid tumors
Gargalionis, A. N., Papavassiliou, K. A., & Papavassiliou, A. G. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166555 · Cited by 33
Mechano-dependent sorbitol accumulation supports biomolecular condensate
Torrino, S., Oldham, W. M., Tejedor, A. R., Sanchez‐Burgos, I., Nasr, L., Rachedi, N., Fraissard, K., Chauvet, C., Sbai, C., O’Hara, B. P., et al. (2024) · Cell · doi:10.1016/j.cell.2024.10.048 · Cited by 32
Self-citationStress responses in stromal cells and tumor homeostasis
Vitale, I., Manic, G., Galassi, C., & Galluzzi, L. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.004 · Cited by 33
CD36 and CD97 in Pancreatic Cancer versus Other Malignancies
Tănase, C., Gheorghișan-Gălățeanu, A.-A., Popescu, I. D., Mihai, S., Codrici, E., Albulescu, R., & Hinescu, M. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165656 · Cited by 32
Zhang, C., Wang, Y., Zhen, Z., Li, J., Su, J., & Wu, C. (2023) · Advanced Science · doi:10.1002/advs.202307206 · Cited by 31
Mukaida, N., Zhang, D., & Sasaki, S. (2020) · Cancers · doi:10.3390/cancers12102896 · Cited by 34
Architectural control of metabolic plasticity in epithelial cancer cells
Al‐Masri, M., Paliotti, K., Tran, R., Halaoui, R., Lelarge, V., Chatterjee, S. J., Wang, L., Moraes, C., & McCaffrey, L. M. (2021) · Communications Biology · doi:10.1038/s42003-021-01899-4 · Cited by 33
Chen, C., Ye, L., Yi, J., Liu, T., & Li, Z. (2023) · Breast Cancer Research and Treatment · doi:10.1007/s10549-023-07032-9 · Cited by 30
Metabo-reciprocity in cell mechanics: feeling the demands/feeding the demand
Torrino, S., & Bertero, T. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.01.013 · Cited by 30
Self-citationLiao, X., Li, X., & Liu, R. R. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09768-z · Cited by 31
Wu, Y., Chen, W., Deng, J., Zhou, X., Chen, J., Yang, Z., Cao, X., Liu, J., Tan, Q., Zhou, E., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113998 · Cited by 38
MacDonald, L., Jenkins, J., Purvis, G., Lee, J. Y., & Franco, A. T. (2020) · Hormones and Cancer · doi:10.1007/s12672-020-00390-6 · Cited by 29
Immuno-Metabolism: The Role of Cancer Niche in Immune Checkpoint Inhibitor Resistance
Weng, C.-Y., Kao, C.-X., Chang, T., & Huang, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031258 · Cited by 29
YAP and TAZ Mediators at the Crossroad between Metabolic and Cellular Reprogramming
Benedetto, G. D., Parisi, S., Russo, T., & Passaro, F. (2021) · Metabolites · doi:10.3390/metabo11030154 · Cited by 29
Dynamic links between mechanical forces and metabolism shape the tumor milieu
Bertolio, R., Napoletano, F., & Sal, G. D. (2023) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2023.102218 · Cited by 28
Hu, X., Peng, X., Zhang, Y., Fan, S., Liu, X., Song, Y., Ren, S., Chen, L., Chen, Y., Wang, R., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155214 · Cited by 29
Xiong, Z., Yu, S.-L., Xie, Z., Zhuang, R., Peng, S., Wang, Q., Gao, Z., Li, B., Xie, J., Huang, H. W., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109674 · Cited by 29
Filipe, E. C., Velayuthar, S., Philp, A. M., Nobis, M., Latham, S. L., Parker, A. L., Murphy, K. J., Wyllie, K., Major, G. S., Contreras, O., et al. (2024) · Advanced Science · doi:10.1002/advs.202307963 · Cited by 26
Stewart, D. C., Brisson, B. K., Dekky, B., Berger, A. C., Yen, W. K., Mauldin, E. A., Loebel, C., GILLETTE, D. M., Assenmacher, C., QUINCEY, C., et al. (2024) · npj Breast Cancer · doi:10.1038/s41523-024-00690-y · Cited by 29
Wang, X. T., Qu, Y., Ji, J., Liu, H., Luo, H., Li, J., & Han, X. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113470 · Cited by 30
Overcoming cancer treatment resistance: Unraveling the role of cancer-associated fibroblasts
Wang, X., Zhou, Y., Wang, Y., Yang, J., Li, Z., Liu, F. L., Wang, A., Gao, Z., Wu, C. H., & Yin, H. (2025) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2025.03.002 · Cited by 32
Blood Vessels and Peripheral Nerves as Key Players in Cancer Progression and Therapy Resistance
Roda, N., Blandano, G., & Pelicci, P. G. (2021) · Cancers · doi:10.3390/cancers13174471 · Cited by 29
Zhang, R., Li, R., Zhang, L., Chen, G., Mo, L., Jiang, R., Xu, X., Wang, X., Zhao, Y., Zhang, L., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c01743 · Cited by 28
The Role of Extracellular Matrix Remodeling in Skin Tumor Progression and Therapeutic Resistance
Fromme, J. E., & Zigrino, P. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.864302 · Cited by 27
Mechanobiology in oncology: basic concepts and clinical prospects
Chen, M. B., Javanmardi, Y., Shahreza, S., Serwinski, B., Aref, A. R., Djordjevic, B., & Moeendarbary, E. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1239749 · Cited by 29
Cancer‐Associated Fibroblasts: Heterogeneity, Cancer Pathogenesis, and Therapeutic Targets
Li, Y., Liu, Q., Jing, X., Wang, Y., Jia, X., Yang, X., & Chen, K. (2025) · MedComm · doi:10.1002/mco2.70292 · Cited by 32
The role of Hippo/YAP1 in cancer-associated fibroblasts: Literature review and future perspectives
Athavale, D., Balch, C., Zhang, Y.-T. Y., Yao, X., & Song, S. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217244 · Cited by 26
The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension
Bertero, T., Perk, D., & Chan, S. Y. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1615438 · Cited by 26
Self-citationJia, S., Bode, A. M., Chen, X., & Luo, X. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189166 · Cited by 27
Chiu, K.-J., Chiou, H.-Y. C., Huang, C.-H., Lu, P.-C., Kuo, H.-R., Wang, J., & Lin, M. (2022) · Biomedicines · doi:10.3390/biomedicines10030713 · Cited by 25
Zhang, X., Wang, Y., Cui, W., Li, D., Song, J., Liu, Y., Liu, Y., & Yang, S. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101273 · Cited by 26
Fan, C., Zhu, W., Chen, Y., Zhu, W., & Ding, J. (2025) · MedComm · doi:10.1002/mco2.70415 · Cited by 30
Immunoscore Predicts Survival in Early-Stage Lung Adenocarcinoma Patients
Zhao, Z., Zhao, D., Ji, X., Wang, Y., & Wang, B. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00691 · Cited by 24
He, C., Peng, M., Zeng, X., Dong, H., Sun, Z., Xu, J., Liu, M., Liu, L., Huang, Y., Peng, Z., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.70131 · Cited by 22
The stiffness of extracellular matrix in regulating cellular metabolism
Zha, B., Zhang, C., & Wu, C. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00913.2024 · Cited by 24
Metabolic adaptations in cancer progression
Peng‐Winkler, Y., & Fendt, S. (2025) · Physiological Reviews · doi:10.1152/physrev.00037.2024 · Cited by 25
SMARCD3 is a potential prognostic marker and therapeutic target in CAFs
Ming, J., Wang, H., Chen, H., & Han, Y. P. (2020) · Aging · doi:10.18632/aging.104102 · Cited by 24
Metabolomics and EMT Markers of Breast Cancer: A Crosstalk and Future Perspective
Pal, A. K., Sharma, P., Zia, A., Siwan, D., Nandave, D., Nandave, M., & Gautam, R. K. (2022) · Pathophysiology · doi:10.3390/pathophysiology29020017 · Cited by 23
Integrative Analysis Reveals the Diverse Effects of 3D Stiffness upon Stem Cell Fate
Yue, M., Liu, Y., Zhang, P., Li, Z., & Zhou, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119311 · Cited by 23
Matrix stiffness regulates nucleus pulposus cell glycolysis by MRTF-A-dependent mechanotransduction
Xu, H., Wei, K., Ni, J., Deng, X., Wang, Y., Xiang, T., Song, F., Wang, Q., Niu, Y., Jiang, F., et al. (2025) · Bone Research · doi:10.1038/s41413-025-00402-7 · Cited by 22
Biological and Clinical Impacts of Glucose Metabolism in Pancreatic Ductal Adenocarcinoma
Liu, Z., Hayashi, H., Matsumura, K., Uemura, N., Shiraishi, Y., Sato, H., & Baba, H. (2023) · Cancers · doi:10.3390/cancers15020498 · Cited by 24
Afshar, K., Sanaei, M., Ravari, M. S., Pourbagheri‐Sigaroodi, A., & Bashash, D. (2023) · Cell Biochemistry and Function · doi:10.1002/cbf.3846 · Cited by 23
Mechanical regulation of metabolism, epigenetics, and their interplay
Nam, H., Yu, G., Ahn, S. I., & Nam, S. (2026) · npj Biomedical Innovations. · doi:10.1038/s44385-025-00059-1 · Cited by 25
Metabolic reprogramming in cancer: signaling pathways and therapeutic targets
Dong, S., & Lei, X. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02582-0 · Cited by 31
Molecular and Metabolic Reprogramming: Pulling the Strings Toward Tumor Metastasis
Hipólito, A., Martins, F., Mendes, C., Lopes‐Coelho, F., & Serpa, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.656851 · Cited by 21
Lee, S.-A., Cho, G.-J., Kim, D., & Kim, D. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1335636 · Cited by 23
Amplifying Tumor–Stroma Communication: An Emerging Oncogenic Function of Mutant p53
Capaci, V., Mantovani, F., & Sal, G. D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.614230 · Cited by 23
Physiological impact of in vivo stable isotope tracing on cancer metabolism
Grima-Reyes, M., Martinez-Turtos, A., Abramovich, I., Gottlieb, E., Chiche, J., & Ricci, J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101294 · Cited by 24
Николаевна, Д. И., Nikonova, E. E., Ignatova, N. I., Koryakina, I., Zyuzin, M. V., Mozherov, A. M., Kozlov, D., Krylov, D. P., Kuznetsova, D. S., Lisitsa, U., et al. (2022) · Cancers · doi:10.3390/cancers14225487 · Cited by 20
Hershey, B. J., Barozzi, S., Orsenigo, F., Pompei, S., Iannelli, F., Kamrad, S., Matafora, V., Pisati, F., Calabrese, L., Fragale, G., et al. (2023) · Science Advances · doi:10.1126/sciadv.adh4184 · Cited by 20
Neurotransmitters: Impressive regulators of tumor progression
Yang, Y., Sun, L., Liu, X., Liu, W., Zhang, Z., Zhou, X., Zhao, X., Zheng, R., Zhang, Y., Guo, W., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116844 · Cited by 20
Mustafa, M., Abbas, K., Alam, M., Habib, S., Zulfareen, Hasan, G. M., Islam, S., Shamsi, A., & Hassan, M. I. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1427802 · Cited by 25
Fibroblasts in cancer: Defining target structures for therapeutic intervention
Boesch, M., Baty, F., Rumpold, H. F., Sopper, S., Wolf, D. G. F., & Brutsche, M. H. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.06.003 · Cited by 20
You, M., Fu, M., Shen, Z., Feng, Y., Zhang, L., Zhu, X., Zhuang, Z., Mao, Y. Q., & Hua, W. (2024) · OncoImmunology · doi:10.1080/2162402x.2024.2356942 · Cited by 20
Interactions between the metabolic reprogramming of liver cancer and tumor microenvironment
Yang, H., Li, J., Niu, Y., Zhou, T., Zhang, P., Liu, Y., & Li, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1494788 · Cited by 23
Falco, P. D., Lazzarino, G., Felice, F., Desideri, E., Castelli, S., Salvatori, I., Ciccarone, F., & Ciriolo, M. R. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102585 · Cited by 20
Xiang, F., Liu, X., Xiang, J., Xu, J., Yin, N., Wang, L., Liu, C., Liu, Y., Zhao, T., Zhao, Z., et al. (2023) · Translational Lung Cancer Research · doi:10.21037/tlcr-23-707 · Cited by 21
Metadata
- Authors
- Bertero, T., Oldham, W. M., Grasset, E. M., Bourget, I., Boulter, E., Pisano, S., Hofman, P., Bellvert, F., Meneguzzi, G., Bulavin, D. V., Estrach, S., Feral, C. C., Chan, S. Y., Bozec, A., & Gaggioli, C.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Brigham and Women's Hospital (US)
- University of Pittsburgh Medical Center (US)
- Corresponding author
- Bertero, Thomas
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 29
- Issue
- 1
- Pages
- 124-140.e10
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC6432652
- OpenAlex
- W2895250239
- Cited by
- 393
- References
- 56
- Citations by year
- 2026: 45 · 2025: 56 · 2024: 71 · 2023: 56 · 2022: 53 · 2021: 49 · 2020: 39 · 2019: 23
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, cc-by-nc)
- Funders
- Ligue Contre le Cancer
- Agence Nationale de la Recherche (ANR-11-LABX-0028-01)
- Association pour la Recherche sur le Cancer (PJA20131200325)
- American Heart Association (HL128802, 18EIA33900027)
- Canceropôle PACA
- Fondation pour la Recherche Médicale (DEQ20180339183)
- National Institutes of Health (HL 138437, UH2 TR002073, HL 122596, R01 HL124021)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- extracellular matrix stiffness, mechanotransduction, glycolysis, glutamine metabolism, amino acid availability, cancer-associated fibroblasts, tumor cell proliferation, aspartic acid, glutamate, redox state, extracellular matrix remodeling, cancer metabolism, metabolic crosstalk, cancer drug targets
- MeSH terms
- Cancer-Associated Fibroblasts, YAP-Signaling Proteins, Transcriptional Coactivator with PDZ-Binding Motif Proteins, Animals, Aspartic Acid, Breast Neoplasms, Carcinoma, Cell Line, Extracellular Matrix, Female, Head and Neck Neoplasms, Humans, Lung Neoplasms, Mice, Inbred BALB C, Transcription Factors, Trans-Activators, Glutamic Acid, Adaptor Proteins, Signal Transducing, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review